Credit Suisse’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $30.2M | Buy |
|
|||||
|
2023
Q4 | $22.6M | Buy |
|
|||||
|
2023
Q3 | $18.2M | Sell |
|
|||||
|
2023
Q2 | $20.6M | Buy |
|
|||||
|
2023
Q1 | $18M | Buy |
|
|||||
|
2022
Q4 | $16.2M | Sell |
|
|||||
|
2022
Q3 | $16.6M | Buy |
|
|||||
|
2022
Q2 | $16.8M | Buy |
|
|||||
|
2022
Q1 | $14.4M | Buy |
|
|||||
|
2021
Q4 | $10.6M | Buy |
|
|||||
|
2021
Q3 | $5.61M | Buy |
|
|||||
|
2021
Q2 | $6.18M | Buy |
|
|||||
|
2021
Q1 | $5.06M | Buy |
|
|||||
|
2020
Q4 | $3.82M | Buy |
|